InsidersTradesSigma
Explore the full record of transactions filed by Duker Jay S., Chief Executive Officer. Director active across 2 companies, notably EyePoint Pharmaceuticals, Inc.. Cumulatively, 3 disclosures have been logged. Activity tracked since 9 February 2022. The latest transaction was disclosed on 22 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
3 of 3 declarations
Jay S. Duker is the Chief Operating Officer and Board Member of EyePoint Pharmaceuticals, Inc. and Sesen Bio, Inc. In this role, he oversees the operations of both companies and contributes to strategic direction. His experience in the pharmaceutical sector is essential in guiding growth and innovation within these organizations. He plays a key role in decision-making that impacts the performance of the companies.